Fred Hutch opened COVID-19 clinical research center
On Oct. 5, 2020, the Fred Hutchinson Cancer Research Center announced the opening of the COVID-19 Clinical Research…
On Oct. 5, 2020, the Fred Hutchinson Cancer Research Center announced the opening of the COVID-19 Clinical Research…
On Oct. 5, 2021, the Nobel Prize in Chemistry 2020 was awarded to Benjamin List and David MacMillan…
On Oct. 1, 2020, the FDA approved Opdivo (nivolumab) in combination with Yervoy (ipilimumab) for the first-line treatment…
On Oct. 2, 2020, AstraZeneca announced the phase I/II clinical trial for the COVID-19 vaccine AZD1222 had resumed…
On Oct. 2, 2020, the National Science Foundation announced investments in 24 new projects to drive future manufacturing….
On Oct. 2, 2020, Yale scientists announced construction of the next-generation human brain PET scanner, the NeuroeXplorer (NX),…
On Oct. 2, 2020, the WHO and the Kingdom of Saudi Arabia signed a contribution agreement in the…
On Oct. 2, 2020, Quidel announced that it had received Emergency Use Authorization from the U.S. Food and…
On Oct. 2, 2020, Humanigen announced that a patient case report on the use of lenzilumabル in critical…
On Oct. 2, 2020, the Uconn Office of the Vice President for Research (OVPR) (OVPR) announced a new…
On Oct. 2, 2020, LabCorp announced that it had received an Emergency Use Authorization (EUA) from the FDA…
On Oct. 1, 2020, widespread accurate testing for SARS-CoV-2, the virus that causes COVID-19, is one critical aspect…
On Oct. 1, 2020, american hospitals began purchasing Veklury (remdesivir) directly from the drugメs distributor. Veklury is an…
On Oct. 1, 2020, Gilead Sciences announced that it will be responsible for distributing Veklury in the U.S….
On Oct. 1, 2020, Amyris announced that it has begun delivering samples to pharmaceutical companies of a sustainable…
On Oct. 1, 2020, Johnson & Johnson announced it had successfully completed its acquisition of Momenta Pharmaceuticals, a…
On Sept. 30, 2020, researchers at the Karolinska Institutet in Sweden and the Max Planck Institute for Evolutionary…
On Sept. 30, 2020, the NIH announced that it had awarded nearly $234 million to improve COVID-19 testing…
On Sept. 30, 2020, University of Oxford researchers announced they had begun a new study to explore the…
On Sept. 30, 2020, the National Science Foundation (NSF) announced that it had funded more than 80 startups…
On Sept. 30, 2020, the National Institutes of Health (NIH) announced funding of a nationwide study to discover…
On Sept. 30, 2020, the United Nations and its partners announced that nearly $1 billion in financing was…
On Sept. 30, 2020, ViralClear Pharmaceuticals and Sorrento Therapeutics announced the companies were exploring the synergistic potential of…
On Sept. 30, 2020, Bio-Techne announced the opening of its approximately 61,000 square foot state-of-the-art GMP (Good Manufacturing…
On Sept. 30, 2020, Quest Diagnostics announced three different test options for healthcare providers across the U.S.to aid…
On Sept. 30, 2020, BD (Becton, Dickinson) announced its rapid, point-of-care, SARS-CoV-2 antigen test for use on the…
On Sept. 30, 2020, Pfizer and BioNTech announced that preliminary, peer-reviewed data from their ongoing German Phase 1/2…
On Sept. 30, 2020, researchers from the Perelman School of Medicine at the University of Pennsylvania reported results…
On Sept. 29, 2020, AXIM Biotechnologies announced that it had filed a provisional patent for a first-in-class face…
On Sept. 29, 2020, Windtree Therapeutics announced that FDA had accepted its Investigational New Drug application for a…